Growth inhibition by insulin-like growth factor-binding protein-3 in T47D breast cancer cells requires transforming growth factor-beta (TGF-beta ) and the type II TGF-beta receptor (Q42493428)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Growth inhibition by insulin-like growth factor-binding protein-3 in T47D breast cancer cells requires transforming growth factor-beta (TGF-beta ) and the type II TGF-beta receptor	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

1 November 2017

Growth inhibition by insulin-like growth factor-binding protein-3 in T47D breast cancer cells requires transforming growth factor-beta (TGF-beta ) and the type II TGF-beta receptor (English)

1 reference

Europe PubMed Central

1 November 2017

1

1 reference

Europe PubMed Central

1 November 2017

Robert C Baxter

4

1 reference

Europe PubMed Central

1 November 2017

author name string

Firth SM

2

1 reference

Europe PubMed Central

1 November 2017

Butt AJ

3

1 reference

Europe PubMed Central

1 November 2017

language of work or name

0 references

publication date

1 December 2000

1 reference

Europe PubMed Central

1 November 2017

Journal of Biological Chemistry

1 reference

Europe PubMed Central

1 November 2017

275

1 reference

Europe PubMed Central

1 November 2017

39146-39151

1 reference

Europe PubMed Central

1 November 2017

50

1 reference

Europe PubMed Central

1 November 2017

TGF-beta stimulation and inhibition of cell proliferation: new mechanistic insights

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M006964200

21 January 2018

Interaction of growth factors during progression towards steroid independence in T-47-D human breast cancer cells

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M006964200

21 January 2018

Beta-transforming growth factor is stored in human blood platelets as a latent high molecular weight complex.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M006964200

21 January 2018

Specific binding to cultured cells of 125I-labeled type beta transforming growth factor from human platelets

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M006964200

21 January 2018

Reduced expression of transforming growth factor beta type I receptor contributes to the malignancy of human colon carcinoma cells

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M006964200

21 January 2018

TGF-beta signalling from cell membrane to nucleus through SMAD proteins

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M006964200

21 January 2018

TGF-beta receptor-mediated signalling through Smad2, Smad3 and Smad4

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M006964200

21 January 2018

Regulation of transforming growth factor beta- and activin-induced transcription by mammalian Mad proteins

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M006964200

21 January 2018

The TGF-beta family mediator Smad1 is phosphorylated directly and activated functionally by the BMP receptor kinase

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M006964200

21 January 2018

Phosphorylation of Ser465 and Ser467 in the C terminus of Smad2 mediates interaction with Smad4 and is required for transforming growth factor-beta signaling

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M006964200

21 January 2018

DPC4, a candidate tumor suppressor gene at human chromosome 18q21.1

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M006964200

21 January 2018

Partnership between DPC4 and SMAD proteins in TGF-beta signalling pathways.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M006964200

21 January 2018

Smad6 inhibits signalling by the TGF-beta superfamily.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M006964200

21 January 2018

Identification of Smad7, a TGFbeta-inducible antagonist of TGF-beta signalling

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M006964200

21 January 2018

Heteromeric and homomeric interactions correlate with signaling activity and functional cooperativity of Smad3 and Smad4/DPC4

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M006964200

21 January 2018

Insulin-like growth factor binding proteins in the human circulation: a review.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M006964200

21 January 2018

Binding proteins for the insulin-like growth factors: structure, regulation and function

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M006964200

21 January 2018

Development of resistance to insulin-like growth factor binding protein-3 in transfected T47D breast cancer cells.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M006964200

21 January 2018

Cloning and expression of the growth hormone-dependent insulin-like growth factor-binding protein.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M006964200

21 January 2018

Single-Step Method of RNA Isolation by Acid Guanidinium Thiocyanate–Phenol–Chloroform Extraction

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M006964200

21 January 2018

Production of an insulin-like growth factor (IGF)-inducible IGF-binding protein by human skin fibroblasts

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M006964200

21 January 2018

Distribution and modulation of the cellular receptor for transforming growth factor-beta

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M006964200

21 January 2018

TGFbeta signaling: receptors, transducers, and Mad proteins.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M006964200

21 January 2018

Genetic changes in the transforming growth factor beta (TGF-beta) type II receptor gene in human gastric cancer cells: correlation with sensitivity to growth inhibition by TGF-beta

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M006964200

21 January 2018

Attenuated ALK5 receptor expression in human pancreatic cancer: correlation with resistance to growth inhibition

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M006964200

21 January 2018

Expression profile of agonistic Smads in human breast cancer cells: absence of regulation by estrogens.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M006964200

21 January 2018

Insulin-like growth factor binding protein 3 (IGF-BP3) inhibits estrogen-stimulated breast cancer cell proliferation

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M006964200

21 January 2018

Estradiol and antiestrogens regulate a growth inhibitory insulin-like growth factor binding protein 3 autocrine loop in human breast cancer cells

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M006964200

21 January 2018

Insulin-like growth factor-binding protein enhancement of insulin-like growth factor-I (IGF-I)-mediated DNA synthesis and IGF-I binding in a human breast carcinoma cell line

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M006964200

21 January 2018

Type beta transforming growth factor: a bifunctional regulator of cellular growth

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M006964200

21 January 2018

Evidence that transforming growth factor-beta is a hormonally regulated negative growth factor in human breast cancer cells

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M006964200

21 January 2018

Transforming growth factor-beta-induced cell growth inhibition in human breast cancer cells is mediated through insulin-like growth factor-binding protein-3 action.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M006964200

21 January 2018

Insulin-like growth factor (IGF)-binding protein-3 induces apoptosis and mediates the effects of transforming growth factor-beta1 on programmed cell death through a p53- and IGF-independent mechanism

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M006964200

21 January 2018

Induction of the growth inhibitor IGF-binding protein 3 by p53

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M006964200

21 January 2018

Oncogenic ras causes resistance to the growth inhibitor insulin-like growth factor binding protein-3 (IGFBP-3) in breast cancer cells.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M006964200

21 January 2018

Identifiers

10.1074/JBC.M006964200

1 reference

Europe PubMed Central

1 November 2017

1 reference

Europe PubMed Central

1 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42493428&oldid=1959619646"